Journal Article
. 2016 Jan; 34(9):927-35.
doi: 10.1200/JCO.2015.62.3504.

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

Marco Colleoni 1 Zhuoxin Sun 2 Karen N Price 2 Per Karlsson 2 John F Forbes 2 Beat Thürlimann 2 Lorenzo Gianni 2 Monica Castiglione 2 Richard D Gelber 2 Alan S Coates 2 Aron Goldhirsch 2 
Affiliations
  • PMID: 26786933
  •     32 References
  •     119 citations

Abstract

Purpose: Predicting the pattern of recurrence can aid in the development of targeted surveillance and treatment strategies. We identified patient populations that remain at risk for an event at a median follow-up of 24 years from the diagnosis of operable breast cancer.

Patients And Methods: International Breast Cancer Study Group clinical trials I to V randomly assigned 4,105 patients between 1978 and 1985. Annualized hazards were estimated for breast cancer-free interval (primary end point), disease-free survival, and overall survival.

Results: For the entire group, the annualized hazard of recurrence was highest during the first 5 years (10.4%), with a peak between years 1 and 2 (15.2%). During the first 5 years, patients with estrogen receptor (ER)--positive disease had a lower annualized hazard compared with those with ER-negative disease (9.9% v 11.5%; P = .01). However, beyond 5 years, patients with ER-positive disease had higher hazards (5 to 10 years: 5.4% v 3.3%; 10 to 15 years: 2.9% v 1.3%; 15 to 20 years: 2.8% v 1.2%; and 20 to 25 years: 1.3% v 1.4%; P < .001). Among patients with ER-positive disease, annualized hazards of recurrence remained elevated and fairly stable beyond 10 years, even for those with no axillary involvement (2.0%, 2.1%, and 1.1% for years 10 to 15, 15 to 20, and 20 to 25, respectively) and for those with one to three positive nodes (3.0%, 3.5%, and 1.5%, respectively).

Conclusion: Patients with ER-positive breast cancer maintain a significant recurrence rate during extended follow up. Strategies for follow up and treatments to prevent recurrences may be most efficiently applied and studied in patients with ER-positive disease followed for a long period of time.

Breast cancer adjuvant therapy: time to consider its time-dependent effects.
Ismail Jatoi, William F Anderson, Jong-Hyeon Jeong, Carol K Redmond.
J Clin Oncol, 2011 May 11; 29(17). PMID: 21555693    Free PMC article.
Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), R Peto, +15 authors, K Pritchard.
Lancet, 2011 Dec 14; 379(9814). PMID: 22152853    Free PMC article.
Highly Cited.
Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors: the case for.
J Michael Dixon, David A Montgomery.
Breast Cancer Res, 2009 Jan 16; 10 Suppl 4. PMID: 19128445    Free PMC article.
'Cure' from breast cancer among two populations of women followed for 23 years after diagnosis.
L M Woods, B Rachet, P C Lambert, M P Coleman.
Ann Oncol, 2009 May 26; 20(8). PMID: 19465419
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), C Davies, +11 authors, R Peto.
Lancet, 2011 Aug 02; 378(9793). PMID: 21802721    Free PMC article.
Highly Cited.
Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer.
M W Retsky, R Demicheli, +2 authors, I D Gukas.
APMIS, 2008 Oct 07; 116(7-8). PMID: 18834415
Review.
Cancer micrometastasis and tumour dormancy.
Harriet Wikman, Robert Vessella, Klaus Pantel.
APMIS, 2008 Oct 07; 116(7-8). PMID: 18834417
Review.
Effect of systemic adjuvant treatment on first sites of breast cancer relapse.
A Goldhirsch, R D Gelber, +7 authors, G Marini.
Lancet, 1994 Feb 12; 343(8894). PMID: 7905550
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
M Gnant, M Filipits, +22 authors, Austrian Breast and Colorectal Cancer Study Group.
Ann Oncol, 2013 Dec 19; 25(2). PMID: 24347518
Highly Cited.
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.
A Goldhirsch, E P Winer, +5 authors, Panel members.
Ann Oncol, 2013 Aug 07; 24(9). PMID: 23917950    Free PMC article.
Highly Cited.
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting.
James L Khatcheressian, Antonio C Wolff, +7 authors, American Society of Clinical Oncology.
J Clin Oncol, 2006 Oct 13; 24(31). PMID: 17033037
Highly Cited.
Are patients diagnosed with breast cancer before age 50 years ever cured?
Hermann Brenner, Timo Hakulinen.
J Clin Oncol, 2003 Dec 24; 22(3). PMID: 14691121
A parametric model for long-term follow-up data from phase III breast cancer clinical trials.
Jong-Hyeon Jeong, Sin-Ho Jung, Samuel Wieand.
Stat Med, 2003 Jan 17; 22(3). PMID: 12529867
Comparison of breast cancer recurrence and outcome patterns between patients treated from 1986 to 1992 and from 2004 to 2008.
Rachel J D Cossetti, Scott K Tyldesley, +2 authors, Karen A Gelmon.
J Clin Oncol, 2014 Nov 26; 33(1). PMID: 25422485
Do estimates of long-term survival tell us whether patients diagnosed with breast cancer before age 50 years are ever cured?
Stephanie Green.
J Clin Oncol, 2003 Dec 24; 22(3). PMID: 14691128
Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer.
Ryung S Kim, Alvaro Avivar-Valderas, +4 authors, Jeffrey E Segall.
PLoS One, 2012 Apr 25; 7(4). PMID: 22530051    Free PMC article.
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study.
Gianni Bonadonna, Angela Moliterni, +4 authors, Pinuccia Valagussa.
BMJ, 2005 Jan 15; 330(7485). PMID: 15649903    Free PMC article.
Tumor dormancy and immunoescape.
Bruno Quesnel.
APMIS, 2008 Oct 07; 116(7-8). PMID: 18834412
Review.
Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.
Otto Metzger-Filho, Zhuoxin Sun, +8 authors, Fatima Cardoso.
J Clin Oncol, 2013 Jul 31; 31(25). PMID: 23897954    Free PMC article.
Highly Cited.
Metastasis dormancy in estrogen receptor-positive breast cancer.
Xiang H-F Zhang, Mario Giuliano, +2 authors, C Kent Osborne.
Clin Cancer Res, 2013 Dec 04; 19(23). PMID: 24298069    Free PMC article.
Highly Cited. Review.
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.
Olivia Pagani, Karen N Price, +9 authors, International Breast Cancer Study Group (IBCSG).
Breast Cancer Res Treat, 2009 Jan 13; 117(2). PMID: 19137426    Free PMC article.
Reliability of steroid hormone receptor assays: an international study.
V C Jordan, D T Zava, +8 authors, J L Wittliff.
Eur J Cancer Clin Oncol, 1983 Mar 01; 19(3). PMID: 6683173
Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer.
Ludwig Breast Cancer Study Group.
N Engl J Med, 1989 Feb 23; 320(8). PMID: 2644533
The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up.
M Castiglione-Gertsch, C Johnsen, +7 authors, J Forbes.
Ann Oncol, 1994 Oct 01; 5(8). PMID: 7826904
The natural history of hormone receptor-positive breast cancer.
Elgene Lim, Otto Metzger-Filho, Eric P Winer.
Oncology (Williston Park), 2012 Sep 11; 26(8). PMID: 22957400
Review.
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast.
J W Meakin, J L Hayward, +10 authors, W D Rider.
Breast Cancer Res Treat, 1996 Jan 01; 37(1). PMID: 8750523
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG).
Lancet, 2005 May 17; 365(9472). PMID: 15894097
Highly Cited.
Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle.
Ludwig Breast Cancer Study Group.
N Engl J Med, 1988 Sep 15; 319(11). PMID: 2901037
Factors predicting late recurrence for estrogen receptor-positive breast cancer.
Ivana Sestak, Mitch Dowsett, +4 authors, Jack Cuzick.
J Natl Cancer Inst, 2013 Sep 14; 105(19). PMID: 24029245    Free PMC article.
Highly Cited.
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.
EBCTCG (Early Breast Cancer Trialists' Collaborative Group), P McGale, +11 authors, S Darby.
Lancet, 2014 Mar 25; 383(9935). PMID: 24656685    Free PMC article.
Highly Cited.
Natural history of human breast cancer: recent data and clinical implications.
M Tubiana, S Koscielny.
Breast Cancer Res Treat, 1991 Aug 01; 18(3). PMID: 1756255
Review.
Annual hazard rates of recurrence for breast cancer after primary therapy.
T Saphner, D C Tormey, R Gray.
J Clin Oncol, 1996 Oct 01; 14(10). PMID: 8874335
Highly Cited.
Utility of Clinical Breast Examinations in Detecting Local-Regional Breast Events After Breast-Conservation in Women with a Personal History of High-Risk Breast Cancer.
Heather B Neuman, Jessica R Schumacher, +9 authors, Caprice C Greenberg.
Ann Surg Oncol, 2016 Aug 06; 23(10). PMID: 27491784    Free PMC article.
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
Armando E Giuliano, Karla Ballman, +7 authors, Kelly K Hunt.
Ann Surg, 2016 Aug 12; 264(3). PMID: 27513155    Free PMC article.
Highly Cited.
Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes.
Hang Yin, Yuanyuan Qu, +9 authors, Qingyong Xu.
Oncotarget, 2017 May 10; 8(30). PMID: 28484094    Free PMC article.
MLK3 regulates FRA-1 and MMPs to drive invasion and transendothelial migration in triple-negative breast cancer cells.
C Rattanasinchai, B J Llewellyn, S E Conrad, K A Gallo.
Oncogenesis, 2017 Jun 13; 6(6). PMID: 28604765    Free PMC article.
Extended adjuvant endocrine therapy in early breast cancer: a meta-analysis of published randomized trials.
Ezzeldin M Ibrahim, Marwan R Al-Hajeili, +2 authors, Ahmed A Refae.
Med Oncol, 2017 Jun 18; 34(7). PMID: 28620883
Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine.
Jane Bayani, Cindy Q Yao, +13 authors, John M S Bartlett.
NPJ Breast Cancer, 2017 Jun 27; 3. PMID: 28649643    Free PMC article.
Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials.
Poornima Saha, Meredith M Regan, +25 authors, International Breast Cancer Study Group.
J Clin Oncol, 2017 Jun 28; 35(27). PMID: 28654365    Free PMC article.
Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance).
Judy C Boughey, Karla V Ballman, +5 authors, Kelly K Hunt.
Ann Surg, 2017 Jun 29; 266(4). PMID: 28657941    Free PMC article.
21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.
Gulisa Turashvili, Joanne F Chou, +5 authors, Hannah Y Wen.
Breast Cancer Res Treat, 2017 Jul 14; 166(1). PMID: 28702894    Free PMC article.
Learning from big data: are we undertreating older women with high-risk breast cancer?
Joseph A Sparano, Hyman Muss.
NPJ Breast Cancer, 2017 Jul 20; 2. PMID: 28721380    Free PMC article.
Tamoxifen therapy benefit for patients with 70-gene signature high and low risk.
Laura J van 't Veer, Christina Yau, +6 authors, Linda Sofie Lindström.
Breast Cancer Res Treat, 2017 Aug 05; 166(2). PMID: 28776283    Free PMC article.
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Armando E Giuliano, Karla V Ballman, +11 authors, Monica Morrow.
JAMA, 2017 Sep 13; 318(10). PMID: 28898379    Free PMC article.
Highly Cited.
Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010.
Judith A Malmgren, Musa Mayer, Mary K Atwood, Henry G Kaplan.
Breast Cancer Res Treat, 2017 Oct 19; 167(2). PMID: 29039120    Free PMC article.
Metastatic breast cancer: Endocrine therapy landscape reshaped.
Mohamad Adham Salkeni, Samantha June Hall.
Avicenna J Med, 2017 Nov 10; 7(4). PMID: 29119080    Free PMC article.
Review.
Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.
Linda S Lindström, Christina Yau, +19 authors, STO Trialists Group.
J Natl Cancer Inst, 2018 Jan 24; 110(7). PMID: 29361175    Free PMC article.
Stanniocalcin Expression as a Predictor of Late Breast Cancer Recurrence.
Kristen D Brantley, Anders Kjærsgaard, +5 authors, Timothy L Lash.
Cancer Epidemiol Biomarkers Prev, 2018 Mar 30; 27(6). PMID: 29593009    Free PMC article.
Patterns of breast cancer relapse in accordance to biological subtype.
Atanas Ignatov, Holm Eggemann, Elke Burger, Tanja Ignatov.
J Cancer Res Clin Oncol, 2018 Apr 21; 144(7). PMID: 29675790
Conditional relative survival among long-term survivors of adolescent and young adult cancers.
Chelsea Anderson, Andrew B Smitherman, Hazel B Nichols.
Cancer, 2018 May 10; 124(14). PMID: 29742278    Free PMC article.
Late distant recurrence of breast carcinoma and metastasis to the main bronchus and choroid: A case report.
Zhijie Luo, Qin Cai, +3 authors, Linzhu Zhai.
Medicine (Baltimore), 2018 May 17; 97(20). PMID: 29768356    Free PMC article.
A prospective feasibility study applying the ACOSOG Z0011 criteria to Japanese patients with early breast cancer undergoing breast-conserving surgery.
Nobuyoshi Kittaka, Ryu Tokui, +5 authors, Yasuhiro Tamaki.
Int J Clin Oncol, 2018 May 24; 23(5). PMID: 29789974
Optimal management of luminal breast cancer: how much endocrine therapy is long enough?
Elisabetta Munzone, Marco Colleoni.
Ther Adv Med Oncol, 2018 Jul 07; 10. PMID: 29977350    Free PMC article.
Review.
Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.
Chara Papadaki, Michalis Stratigos, +5 authors, Sofia Agelaki.
Breast Cancer Res, 2018 Jul 13; 20(1). PMID: 29996899    Free PMC article.
Prophylactic mastectomy for the prevention of breast cancer: Review of the literature.
Rawan K Alaofi, Mohammed O Nassif, Marwan R Al-Hajeili.
Avicenna J Med, 2018 Aug 10; 8(3). PMID: 30090744    Free PMC article.
Review.
Association between the Dietary Inflammatory Index and Risk for Cancer Recurrence and Mortality among Patients with Breast Cancer.
Hyeonjeong Jang, Min Sung Chung, Shin Sook Kang, Yongsoon Park.
Nutrients, 2018 Aug 17; 10(8). PMID: 30111758    Free PMC article.
Genomic Testing in the Management of Early-Stage Breast Cancer.
Sima Ehsani, Kari Braun Wisinski.
J Clin Outcomes Manag, 2017 May 01; 24(5). PMID: 30158821    Free PMC article.
Inborn-like errors of metabolism are determinants of breast cancer risk, clinical response and survival: a study of human biochemical individuality.
Ismael da Silva, Rene da Costa Vieira, +32 authors, Robert Nagourney.
Oncotarget, 2018 Sep 01; 9(60). PMID: 30167086    Free PMC article.
Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast.
Yeji An, Jessica R Adams, +19 authors, Sean E Egan.
Cell Rep, 2018 Oct 18; 25(3). PMID: 30332649    Free PMC article.
Prognostic factors in breast cancer patients evaluated by positron-emission tomography/computed tomography before neoadjuvant chemotherapy.
Mark K Farrugia, Sinjen Wen, Geraldine M Jacobson, Mohamad Adham Salkeni.
World J Nucl Med, 2018 Dec 07; 17(4). PMID: 30505226    Free PMC article.
Bovine herpesvirus 4-based vector delivering the full length xCT DNA efficiently protects mice from mammary cancer metastases by targeting cancer stem cells.
Gaetano Donofrio, Giulia Tebaldi, +7 authors, Federica Cavallo.
Oncoimmunology, 2018 Dec 14; 7(12). PMID: 30524888    Free PMC article.
Race and delays in breast cancer treatment across the care continuum in the Carolina Breast Cancer Study.
Katherine E Reeder-Hayes, Sophie E Mayer, +5 authors, Melissa A Troester.
Cancer, 2019 Aug 10; 125(22). PMID: 31398265    Free PMC article.
The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study.
Tim C de Ruijter, Kim M Smits, +7 authors, Vivianne C G Tjan-Heijnen.
Diagn Progn Res, 2019 Oct 24; 3. PMID: 31641693    Free PMC article.
Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients.
Kjersti Tjensvoll, Oddmund Nordgård, +3 authors, Bjørnar Gilje.
BMC Cancer, 2019 Nov 23; 19(1). PMID: 31752747    Free PMC article.
Use of Breast Imaging After Treatment for Locoregional Breast Cancer (AFT-01).
Taiwo Adesoye, Jessica R Schumacher, +6 authors, Alliance ACS-CRP CCDR Breast Cancer Surveillance Working Group.
Ann Surg Oncol, 2018 Feb 17; 25(6). PMID: 29450753    Free PMC article.
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence.
Fabio Conforti, Laura Pala, +12 authors, Aron Goldhirsch.
Breast Cancer Res, 2020 Jan 01; 21(1). PMID: 31888717    Free PMC article.
The Impact of Bariatric Surgery on Breast Cancer Recurrence: Case Series and Review of Literature.
Shijia Zhang, Sayeed Ikramuddin, +3 authors, Anne H Blaes.
Obes Surg, 2019 Jul 31; 30(2). PMID: 31359344
Review.
ELF5 modulates the estrogen receptor cistrome in breast cancer.
Catherine L Piggin, Daniel L Roden, +12 authors, Christopher J Ormandy.
PLoS Genet, 2020 Jan 03; 16(1). PMID: 31895944    Free PMC article.
Ipsilateral breast tumor recurrence in early stage breast cancer patients treated with breast conserving surgery and adjuvant radiation therapy: Concordance of biomarkers and tumor location from primary tumor to in-breast tumor recurrence.
Juhi M Purswani, Fauzia Shaikh, +5 authors, Naamit K Gerber.
World J Clin Oncol, 2020 Jan 25; 11(1). PMID: 31976307    Free PMC article.
Research-based PAM50 signature and long-term breast cancer survival.
Minya Pu, Karen Messer, +10 authors, Loki Natarajan.
Breast Cancer Res Treat, 2019 Sep 23; 179(1). PMID: 31542876    Free PMC article.
Prognostic Significance of Metabolic Parameters and Textural Features on 18F-FDG PET/CT in Invasive Ductal Carcinoma of Breast.
Chin-Chuan Chang, Chao-Jung Chen, +3 authors, Yu-Chang Tyan.
Sci Rep, 2019 Jul 31; 9(1). PMID: 31358786    Free PMC article.
The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy.
Jordan A Krall, Ferenc Reinhardt, +8 authors, Robert A Weinberg.
Sci Transl Med, 2018 Apr 13; 10(436). PMID: 29643230    Free PMC article.
Highly Cited.
Modulating Bone Marrow Hematopoietic Lineage Potential to Prevent Bone Metastasis in Breast Cancer.
Jessalyn M Ubellacker, Ninib Baryawno, +13 authors, Sandra S McAllister.
Cancer Res, 2018 Aug 02; 78(18). PMID: 30065048    Free PMC article.
FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation.
Shaoqiang Cheng, Yuanxi Huang, +3 authors, Qingyuan Zhang.
Cancer Biol Ther, 2018 Oct 20; 20(3). PMID: 30336071    Free PMC article.
Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions.
Maryse Fiche, Valentina Scabia, +9 authors, Cathrin Brisken.
J Pathol, 2018 Nov 16; 247(3). PMID: 30430577    Free PMC article.
Circulating tumor DNA dynamics using patient-customized assays are associated with outcome in neoadjuvantly treated breast cancer.
Timothy M Butler, Christopher T Boniface, +6 authors, Paul T Spellman.
Cold Spring Harb Mol Case Stud, 2019 Mar 06; 5(2). PMID: 30833418    Free PMC article.
Validation study of MARCKSL1 as a prognostic factor in lymph node-negative breast cancer patients.
Nina Gran Egeland, Marie Austdal, +6 authors, Kristin Jonsdottir.
PLoS One, 2019 Mar 12; 14(3). PMID: 30856208    Free PMC article.
Role of Hedgehog Signaling in Breast Cancer: Pathogenesis and Therapeutics.
Natalia A Riobo-Del Galdo, Ángela Lara Montero, Eva V Wertheimer.
Cells, 2019 Apr 28; 8(4). PMID: 31027259    Free PMC article.
Review.
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy.
Sung Pil Hong, Thalia E Chan, +9 authors, Luca Magnani.
Nat Commun, 2019 Sep 04; 10(1). PMID: 31477698    Free PMC article.
High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial.
Tessa G Steenbruggen, Lars C Steggink, +18 authors, Jourik A Gietema.
JAMA Oncol, 2020 Jan 31; 6(4). PMID: 31999296    Free PMC article.
Predictive factors of 5-year relapse-free survival in HR+/HER2- breast cancer patients treated with neoadjuvant endocrine therapy: pooled analysis of two phase 2 trials.
Florence Lerebours, Marina Pulido, +17 authors, Nathalie Quenel-Tueux.
Br J Cancer, 2020 Feb 01; 122(6). PMID: 32001832    Free PMC article.
Breast cancer stem cell RNA-pulsed dendritic cells enhance tumor cell killing by effector T cells.
Nuttavut Sumransub, Niphat Jirapongwattana, +7 authors, Chanitra Thuwajit.
Oncol Lett, 2020 Mar 21; 19(3). PMID: 32194742    Free PMC article.
Preanalytical Variables for the Genomic Assessment of the Cellular and Acellular Fractions of the Liquid Biopsy in a Cohort of Breast Cancer Patients.
Stephanie N Shishido, Lisa Welter, +14 authors, Peter Kuhn.
J Mol Diagn, 2020 Jan 25; 22(3). PMID: 31978562    Free PMC article.
A National Study of the Use of Asymptomatic Systemic Imaging for Surveillance Following Breast Cancer Treatment (AFT-01).
Jessica R Schumacher, Heather B Neuman, +15 authors, Alliance ACS-CRP CCDR Breast Cancer Surveillance Working Group.
Ann Surg Oncol, 2018 May 20; 25(9). PMID: 29777402    Free PMC article.
Antiproliferative and Antimigration Activities of Fluoro-Neplanocin A via Inhibition of Histone H3 Methylation in Triple-Negative Breast Cancer.
Woong Sub Byun, Won Kyung Kim, +3 authors, Sang Kook Lee.
Biomolecules, 2020 Apr 05; 10(4). PMID: 32244385    Free PMC article.
Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer.
Cinzia Giaccherini, Marina Marchetti, +21 authors, HYPERCAN Investigators.
Haematologica, 2019 Sep 29; 105(6). PMID: 31558668    Free PMC article.
Combination cyclin-dependent kinase 4/6 inhibitors and endocrine therapy versus endocrine monotherapy for hormonal receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: A systematic review and meta-analysis.
Jiani Zheng, Jingxun Wu, +3 authors, Feng Ye.
PLoS One, 2020 Jun 05; 15(6). PMID: 32497134    Free PMC article.
Systematic Review.
Unmet Clinical Need: Developing Prognostic Biomarkers and Precision Medicine to Forecast Early Tumor Relapse, Detect Chemo-Resistance and Improve Overall Survival in High-Risk Breast Cancer.
Gagan Gupta, Caroline Dasom Lee, +10 authors, Amy H Tang.
Ann Breast Cancer Ther, 2020 Jun 17; 4(1). PMID: 32542231    Free PMC article.
Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization.
Jae Young So, Nicolas Skrypek, +14 authors, Li Yang.
Cancer Res, 2020 Apr 09; 80(12). PMID: 32265226    Free PMC article.
Late effects of adjuvant chemotherapy adumbrate dormancy complexity in breast cancer.
Romano Demicheli, Christine Desmedt, +3 authors, Elia Biganzoli.
Breast, 2020 May 20; 52. PMID: 32428688    Free PMC article.
Effect of multidisciplinary team care on the risk of recurrence in breast cancer patients: A national matched cohort study.
Chang-Hung Tsai, Huan-Fa Hsieh, +3 authors, Wen-Chen Tsai.
Breast, 2020 Jul 12; 53. PMID: 32652461    Free PMC article.
Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer.
Nancy Y Yu, Adina Iftimi, +10 authors, Linda S Lindström.
JAMA Oncol, 2019 Aug 09; 5(9). PMID: 31393518    Free PMC article.
Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer.
Christina A Minami, Olga Kantor, +3 authors, Elizabeth A Mittendorf.
J Am Coll Surg, 2020 Aug 11; 231(4). PMID: 32771654    Free PMC article.
Maternal obesity increases offspring's mammary cancer recurrence and impairs tumor immune response.
Xiyuan Zhang, Fabia de Oliveira Andrade, +5 authors, Leena Hilakivi-Clarke.
Endocr Relat Cancer, 2020 Jun 25; 27(9). PMID: 32580156    Free PMC article.
Association between the 21-gene recurrence score and isolated locoregional recurrence in stage I-II, hormone receptor-positive breast cancer.
David D Yang, Daniela L Buscariollo, +11 authors, Rinaa S Punglia.
Radiat Oncol, 2020 Aug 18; 15(1). PMID: 32799886    Free PMC article.
Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients.
Nina Gran Egeland, Kristin Jonsdottir, +7 authors, Emiel A M Janssen.
Clin Epidemiol, 2020 Aug 18; 12. PMID: 32801916    Free PMC article.
Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening.
Sisse Helle Njor, Ilse Vejborg, Mette Bach Larsen.
Cancer Med, 2020 Jul 02; 9(16). PMID: 32608178    Free PMC article.
Cell-free DNA concentration in patients with clinical or mammographic suspicion of breast cancer.
Michal Peled, Ravit Agassi, +8 authors, Amos Douvdevani.
Sci Rep, 2020 Sep 05; 10(1). PMID: 32884019    Free PMC article.
ASO Author Reflections: Use of Breast Imaging After Treatment for Locoregional Breast Cancer (AFT-01).
Taiwo Adesoye, Jessica Schumacher, Caprice C Greenberg.
Ann Surg Oncol, 2018 Dec 20; 26(Suppl 3). PMID: 30565039    Free PMC article.
Selenium donors inhibits osteoclastogenesis through inhibiting IL-6 and plays a pivotal role in bone metastasis from breast cancer.
Luyan Zhang, Xifa Wu, +2 authors, Jinbo Jian.
Toxicol Res (Camb), 2020 Sep 10; 9(4). PMID: 32905216    Free PMC article.
BCL-2 expression aids in the immunohistochemical prediction of the Oncotype DX breast cancer recurrence score.
Mark D Zarella, Rebecca C Heintzelman, Nikolay K Popnikolov, Fernando U Garcia.
BMC Clin Pathol, 2018 Dec 24; 18. PMID: 30574014    Free PMC article.
Access to high-cost drugs for advanced breast cancer in Latin America, particularly trastuzumab.
Carlos Henrique Barrios, Tomás Reinert, Gustavo Werutsky.
Ecancermedicalscience, 2019 Feb 23; 13. PMID: 30792815    Free PMC article.
Review.
Combined Targeting of Estrogen Receptor Alpha and XPO1 Prevent Akt Activation, Remodel Metabolic Pathways and Induce Autophagy to Overcome Tamoxifen Resistance.
Eylem Kulkoyluoglu-Cotul, Brandi Patrice Smith, +12 authors, Zeynep Madak-Erdogan.
Cancers (Basel), 2019 Apr 17; 11(4). PMID: 30987380    Free PMC article.
Diagnosis of Primary Colorectal Carcinoma with Primary Breast Cancer: Associations or Connections?
Simcha Weissman, Jefferey Sebrow, +6 authors, Saad Saleem.
Cureus, 2019 Jun 12; 11(3). PMID: 31183268    Free PMC article.
Dynamic and subtype-specific interactions between tumour burden and prognosis in breast cancer.
S B Lee, H-K Kim, +13 authors, H-G Moon.
Sci Rep, 2020 Sep 24; 10(1). PMID: 32963275    Free PMC article.
Early treatment-related neutropenia predicts response to palbociclib.
Nicholas P McAndrew, Mark A Dickson, +10 authors, Angela DeMichele.
Br J Cancer, 2020 Jul 10; 123(6). PMID: 32641862    Free PMC article.
Inter-tumor genomic heterogeneity of breast cancers: comprehensive genomic profile of primary early breast cancers and relapses.
Caterina Fumagalli, Alberto Ranghiero, +8 authors, Massimo Barberis.
Breast Cancer Res, 2020 Oct 17; 22(1). PMID: 33059724    Free PMC article.
Assessment of IGF-1 expression in the peripheral blood of women with recurrent breast cancer.
Danylo Rafhael Costa-Silva, Maria da Conceição Barros-Oliveira, +18 authors, Benedito Borges da Silva.
Medicine (Baltimore), 2020 Oct 31; 99(43). PMID: 33120836    Free PMC article.
Clinical Implications of Serum 25-Hydroxyvitamin D Status after 5-Year Adjuvant Endocrine Therapy for Late Recurrence of Hormone Receptor-positive Breast Cancer.
Seung Taek Lim, Ye Won Jeon, Hongki Gwak, Young Jin Suh.
J Breast Cancer, 2020 Nov 07; 23(5). PMID: 33154825    Free PMC article.
Adherence to post-surgery follow-up assessment and its association with sociodemographic and disease characteristics in patients with breast cancer in Central China.
Ran Feng, Jingfeng Jing, +2 authors, Jinnan Gao.
BMC Cancer, 2020 Nov 14; 20(1). PMID: 33183247    Free PMC article.
Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.
Carolyn Cullinane, Christina Fleming, +5 authors, Henry Paul Redmond.
JAMA Netw Open, 2020 Nov 20; 3(11). PMID: 33211112    Free PMC article.
Systematic Review.
Protein Corona Gold Nanoparticles Fingerprinting Reveals a Profile of Blood Coagulation Proteins in the Serum of HER2-Overexpressing Breast Cancer Patients.
María Del Pilar Chantada-Vázquez, Antonio Castro López, +3 authors, Cristina Núñez.
Int J Mol Sci, 2020 Nov 14; 21(22). PMID: 33182810    Free PMC article.
Can Complete Axillary Node Dissection Be Safely Omitted in Patients with Early Breast Cancer When the Sentinel Node Biopsy Is Positive for Malignancy? An Update for Clinical Practice.
Ritika Gera, Abdul Kasem, Kefah Mokbel.
In Vivo, 2018 Oct 24; 32(6). PMID: 30348682    Free PMC article.
Review.
Examination of a paradox: recurrent metastatic breast cancer incidence decline without improved distant disease survival: 1990-2011.
Judith Malmgren, Marc Hurlbert, Mary Atwood, Henry G Kaplan.
Breast Cancer Res Treat, 2018 Dec 19; 174(2). PMID: 30560462    Free PMC article.
Using natural language processing and machine learning to identify breast cancer local recurrence.
Zexian Zeng, Sasa Espino, +6 authors, Yuan Luo.
BMC Bioinformatics, 2018 Dec 29; 19(Suppl 17). PMID: 30591037    Free PMC article.
Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up.
Sherry X Yang, Eric C Polley.
Breast Cancer Res Treat, 2019 Feb 13; 175(2). PMID: 30746635    Free PMC article.
Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis - results from a registry-based study from Germany.
Bernd Holleczek, Christa Stegmaier, +2 authors, Hermann Brenner.
BMC Cancer, 2019 May 31; 19(1). PMID: 31146706    Free PMC article.
Fourth-generation chimeric antigen receptor T cells targeting folate receptor alpha antigen expressed on breast cancer cells for adoptive T cell therapy.
Piriya Luangwattananun, Mutita Junking, +4 authors, Pa-Thai Yenchitsomanus.
Breast Cancer Res Treat, 2021 Jan 04; 186(1). PMID: 33389403
The lingering mysteries of metastatic recurrence in breast cancer.
Alessandra I Riggio, Katherine E Varley, Alana L Welm.
Br J Cancer, 2020 Nov 27; 124(1). PMID: 33239679    Free PMC article.
Review.
Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies.
Kevin H Kensler, Elizabeth M Poole, +10 authors, Rulla M Tamimi.
J Natl Cancer Inst, 2018 Nov 18; 111(7). PMID: 30445651    Free PMC article.
Long-Term Prognostication for 20 114 Women With Small and Node-Negative Breast Cancer (T1abN0).
David Jaraj, Jonas Höijer, +9 authors, Pettersson Andreas.
JNCI Cancer Spectr, 2021 Jan 15; 5(1). PMID: 33442658    Free PMC article.
The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
Wakako Tajiri, Hideki Ijichi, +8 authors, Eriko Tokunaga.
Breast Cancer, 2020 Jul 01; 28(1). PMID: 32601800    Free PMC article.
Impact of Hormone Receptor Status on the Behaviour of HER2+ Breast Cancer.
Iveta Kolarova, Ladislav Dusek, +11 authors, Jiri Jarkovsky.
In Vivo, 2020 Nov 05; 34(6). PMID: 33144452    Free PMC article.
Genistein Reduces the Risk of Local Mammary Cancer Recurrence and Ameliorates Alterations in the Gut Microbiota in the Offspring of Obese Dams.
Fabia de Oliveira Andrade, Fang Liu, +7 authors, Leena Hilakivi-Clarke.
Nutrients, 2021 Jan 15; 13(1). PMID: 33440675    Free PMC article.
Cost-effectiveness of MR-mammography as a solitary imaging technique in women with dense breasts: an economic evaluation of the prospective TK-Study.
Matthias F Froelich, Clemens G Kaiser.
Eur Radiol, 2020 Aug 29; 31(2). PMID: 32856166    Free PMC article.
Intensity of metastasis screening and survival outcomes in patients with breast cancer.
Jong-Ho Cheun, Jigwang Jung, +8 authors, Hyeong-Gon Moon.
Sci Rep, 2021 Feb 04; 11(1). PMID: 33531549    Free PMC article.
Validation of the Role of Thrombin Generation Potential by a Fully Automated System in the Identification of Breast Cancer Patients at High Risk of Disease Recurrence.
Patricia Gomez-Rosas, Marina Pesenti, +19 authors, HYPERCAN Investigators.
TH Open, 2021 Feb 16; 5(1). PMID: 33585786    Free PMC article.
Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry.
José P Leone, Bernardo A Leone, +7 authors, Nancy U Lin.
Breast Cancer Res Treat, 2021 Feb 17; 187(3). PMID: 33590387
Does Failure to Achieve Pathologic Complete Response with Neoadjuvant Chemotherapy Identify Node-Negative Patients Who Would Benefit from Postmastectomy Radiation or Regional Nodal Irradiation?
Angelena Crown, Mithat Gonen, Tiana Le, Monica Morrow.
Ann Surg Oncol, 2020 Sep 23; 28(3). PMID: 32959140    Free PMC article.
Impact of Pathologic Complete Response following Neoadjuvant Chemotherapy ± Trastuzumab in Locally Advanced Breast Cancer.
Taher Al-Tweigeri, Mahmoud Elshenawy, +9 authors, Adher Al Sayed.
J Oncol, 2021 Feb 26; 2021. PMID: 33628241    Free PMC article.
PD-L1 Protein Expression in Middle Eastern Breast Cancer Predicts Favorable Outcome in Triple-Negative Breast Cancer.
Sandeep Kumar Parvathareddy, Abdul K Siraj, +6 authors, Khawla S Al-Kuraya.
Cells, 2021 Jan 29; 10(2). PMID: 33503961    Free PMC article.
Early Discontinuation of Endocrine Therapy and Recurrence of Breast Cancer among Premenopausal Women.
Lindsay J Collin, Deirdre P Cronin-Fenton, +10 authors, Timothy L Lash.
Clin Cancer Res, 2020 Dec 19; 27(5). PMID: 33334905    Free PMC article.
Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer.
Allegra Freelander, Lauren J Brown, +4 authors, Elgene Lim.
Genes (Basel), 2021 Mar 07; 12(2). PMID: 33671468    Free PMC article.
Review.
Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation.
Molly B Moravek, Rafael Confino, +6 authors, Mary Ellen Pavone.
Breast Cancer Res Treat, 2021 Jan 05; 186(2). PMID: 33392838
Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment.
Kathleen Beusterien, Martine C Maculaitis, +3 authors, Ernest H Law.
Patient Prefer Adherence, 2021 Mar 30; 15. PMID: 33776424    Free PMC article.
A Clinical Decision Support System for Predicting Invasive Breast Cancer Recurrence: Preliminary Results.
Raffaella Massafra, Agnese Latorre, +13 authors, Vito Lorusso.
Front Oncol, 2021 Mar 30; 11. PMID: 33777733    Free PMC article.
Opioid Use Disorder and Overdose in Older Adults With Breast, Colorectal, or Prostate Cancer.
Andrew W Roberts, Samantha Eiffert, +2 authors, Devon K Check.
J Natl Cancer Inst, 2020 Aug 18; 113(4). PMID: 32805032    Free PMC article.
Loco-regional recurrence trend and prognosis in young women with breast cancer according to molecular subtypes: analysis of 1099 cases.
Yang Li, Su Lu, +2 authors, Hong Liu.
World J Surg Oncol, 2021 Apr 15; 19(1). PMID: 33849563    Free PMC article.
The development and initial validation of the Breast Cancer Recurrence instrument (BreastCaRe)-a patient-reported outcome measure for detecting symptoms of recurrence after breast cancer.
Beverley Lim Høeg, Lena Saltbæk, +5 authors, Pernille Envold Bidstrup.
Qual Life Res, 2021 Apr 18; 30(9). PMID: 33864164
Factors associated with late risks of breast cancer-specific mortality in the SEER registry.
José P Leone, Carlos T Vallejo, +8 authors, Nancy U Lin.
Breast Cancer Res Treat, 2021 Apr 25; 189(1). PMID: 33893907    Free PMC article.
Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis.
Elizabeth M Salvo, Abril Oliva Ramirez, +4 authors, Imtiaz A Samjoo.
Breast, 2021 Mar 08; 57. PMID: 33677313    Free PMC article.
Evaluation of circulating tumor cells as a prognostic biomarker for early recurrence in stage II-III breast cancer patients using CytoSorter® system: a retrospective study.
Lidan Jin, Wan-Hung Fan, +2 authors, Wenhe Zhao.
PeerJ, 2021 May 15; 9. PMID: 33987029    Free PMC article.
Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells.
Scott Sauer, Damon R Reed, +3 authors, Dalit Barkan.
Front Oncol, 2021 May 15; 11. PMID: 33987095    Free PMC article.
Review.
Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer.
Huimin Lv, Min Yan, Zefei Jiang.
Ther Adv Med Oncol, 2021 May 18; 13. PMID: 33995599    Free PMC article.
Review.
Effects of Diet and Exercise-Induced Weight Loss on Biomarkers of Inflammation in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
Tyler J Bruinsma, Anne-Marie Dyer, +2 authors, Kathleen M Sturgeon.
Cancer Epidemiol Biomarkers Prev, 2021 Mar 20; 30(6). PMID: 33737299    Free PMC article.
Review.
A rude awakening from tumour cells.
Fatima Cardoso, Giuseppe Curigliano.
Nature, 2018 Feb 01; 554(7690). PMID: 32094835
Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells.
Haojun Shi, Yisi Yang.
Cancer Med, 2021 May 02; 10(11). PMID: 33932112    Free PMC article.
Immunoregulatory Monocyte Subset Promotes Metastasis Associated With Therapeutic Intervention for Primary Tumor.
Takumi Shibuya, Asami Kamiyama, +13 authors, Satoshi Yotsumoto.
Front Immunol, 2021 Jun 25; 12. PMID: 34163472    Free PMC article.
Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA.
Justin D Finkle, Hala Boulos, +12 authors, Nike Beaubier.
NPJ Precis Oncol, 2021 Jul 04; 5(1). PMID: 34215841    Free PMC article.
Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
Huma Dar, Annelie Johansson, +9 authors, Linda S Lindström.
JAMA Netw Open, 2021 Jul 01; 4(6). PMID: 34190995    Free PMC article.
Inorganic Nanomaterial-Mediated Gene Therapy in Combination with Other Antitumor Treatment Modalities.
Guanyou Lin, Richard A Revia, Miqin Zhang.
Adv Funct Mater, 2021 Aug 10; 31(5). PMID: 34366761    Free PMC article.